CTC
BMY icon

Cetera Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Cetera Trust Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20K Hold
330
– – 0.01% 255
2025
Q4 		$17.8K Hold
330
– – 0.01% 259
2025
Q3 		$14.9K Hold
330
– – 0.01% 265
2025
Q2 		$15.3K Hold
330
– – 0.01% 262
2025
Q1 		$20.1K Sell
330
-1,550
-82% -$90.3K 0.01% 252
2024
Q4 		$106K Sell
1,880
-88
-4% -$4.92K 0.07% 195
2024
Q3 		$102K Sell
1,968
-15,959
-89% -$749K 0.06% 205
2024
Q2 		$745K Sell
17,927
-2,165
-11% -$96.9K 0.47% 50
2024
Q1 		$1.09M Buy
20,092
+2,325
+13% +$118K 0.66% 42
2023
Q4 		$912K Buy
+17,767
New +$933K 0.57% 44

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cetera Trust Company's BMY Position: Q1 2026 in Review

Cetera Trust Company held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 330 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #255.

Cetera Trust Company first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.09M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cetera Trust Company held 330 shares of Bristol-Myers Squibb worth $20K as of Q1 2026.
  • Cetera Trust Company left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.01% of Cetera Trust Company's portfolio in Q1 2026, its #255 holding.
  • Cetera Trust Company first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Cetera Trust Company's Bristol-Myers Squibb position peaked at $1.09M in Q1 2024.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.